Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections

Filip Jansåker; Niels Frimodt-Møller; Ingegerd Sjögren; Inge Jenny Dahl Knudsen

doi:10.1093/jac/dkt404

Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections

Filip Jansåker, Niels Frimodt-Møller, Ingegerd Sjögren, Inge Jenny Dahl Knudsen

Department of Clinical Microbiology

54 Citations (Scopus)

Abstract

The prevalence of urinary tract infections (UTIs) caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae is increasing and the therapeutic options are limited, especially in primary care. Recent indications have suggested pivmecillinam to be a suitable option. Here, we evaluated the clinical and bacteriological effects of pivmecillinam in UTIs caused by ESBL-producing Enterobacteriaceae.

Original language	English
Journal	The Journal of antimicrobial chemotherapy
Volume	69
Issue number	3
Pages (from-to)	769-772
Number of pages	3
ISSN	0305-7453
DOIs	https://doi.org/10.1093/jac/dkt404
Publication status	Published - Mar 2014

Access to Document

10.1093/jac/dkt404

Cite this

Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections. / Jansåker, Filip; Frimodt-Møller, Niels; Sjögren, Ingegerd et al.
In: The Journal of antimicrobial chemotherapy, Vol. 69, No. 3, 03.2014, p. 769-772.

Research output: Contribution to journal › Journal article › Research › peer-review

@article{627043b119a044998185f27dcbd6686c,

title = "Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections",

abstract = "The prevalence of urinary tract infections (UTIs) caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae is increasing and the therapeutic options are limited, especially in primary care. Recent indications have suggested pivmecillinam to be a suitable option. Here, we evaluated the clinical and bacteriological effects of pivmecillinam in UTIs caused by ESBL-producing Enterobacteriaceae.",

author = "Filip Jans{\aa}ker and Niels Frimodt-M{\o}ller and Ingegerd Sj{\"o}gren and Knudsen, \{Inge Jenny Dahl\}",

year = "2014",

month = mar,

doi = "10.1093/jac/dkt404",

language = "English",

volume = "69",

pages = "769--772",

journal = "The Journal of antimicrobial chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections

AU - Jansåker, Filip

AU - Frimodt-Møller, Niels

AU - Sjögren, Ingegerd

AU - Knudsen, Inge Jenny Dahl

PY - 2014/3

Y1 - 2014/3

N2 - The prevalence of urinary tract infections (UTIs) caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae is increasing and the therapeutic options are limited, especially in primary care. Recent indications have suggested pivmecillinam to be a suitable option. Here, we evaluated the clinical and bacteriological effects of pivmecillinam in UTIs caused by ESBL-producing Enterobacteriaceae.

AB - The prevalence of urinary tract infections (UTIs) caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae is increasing and the therapeutic options are limited, especially in primary care. Recent indications have suggested pivmecillinam to be a suitable option. Here, we evaluated the clinical and bacteriological effects of pivmecillinam in UTIs caused by ESBL-producing Enterobacteriaceae.

UR - https://www.scopus.com/pages/publications/84894088675

U2 - 10.1093/jac/dkt404

DO - 10.1093/jac/dkt404

M3 - Journal article

C2 - 24107388

SN - 0305-7453

VL - 69

SP - 769

EP - 772

JO - The Journal of antimicrobial chemotherapy

JF - The Journal of antimicrobial chemotherapy

IS - 3

ER -

Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections

Abstract

Access to Document

Other files and links

Fingerprint

Cite this